Altasciences, a holding company, includes Algorithme Pharma (Quebec, Canada), Algorithme Pharma USA (Fargo, North Dakota) and Vince & Associates Clinical Research (Kansas, USA), which provide comprehensive early stage clinical drug development services in Phase I/ IIa, including the necessary support services in this critical stage of drug development.
The capabilities available at Altasciences provide a multi-site solution to increasingly complex early stage clinical drug development needs.
The team, of almost 500 professionals from the medical and scientific fields, works together to conduct Phase I/IIa, Bioequivalence and 505(b)(2) studies, involving over 5,000 participants annually including patient populations.
Capitalizing on our extensive background within our fields of expertise, we aim to help the scientific industry with the mission to promote discussion on the life sciences practices.
We have contributed to many scientific papers, publications and presentations in international conferences.